COMMON STOCK PURCHASE WARRANT ZYVERSA THERAPEUTICS, INC.Common Stock Purchase Warrant • April 18th, 2023 • ZyVersa Therapeutics, Inc. • Pharmaceutical preparations
Contract Type FiledApril 18th, 2023 Company IndustryTHIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time or times on or after April [●], 2023 (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on the five-year anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from ZyVersa Therapeutics, Inc., a Delaware corporation (the “Company”), up to [●] shares of common stock, par value $0.0001 per share (the “Common Stock”) (as subject to adjustment hereunder, the “Warrant Shares”). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
Attn: Chief Executive Officer ZyVersa Therapeutics, Inc.Placement Agent Agreement • April 18th, 2023 • ZyVersa Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledApril 18th, 2023 Company Industry Jurisdiction
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • April 18th, 2023 • ZyVersa Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledApril 18th, 2023 Company Industry JurisdictionThis SECURITIES PURCHASE AGREEMENT (this “Agreement”) is dated as of April [●], 2023, between ZyVersa Therapeutics, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
ESCROW AGREEMENTEscrow Agreement • April 18th, 2023 • ZyVersa Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledApril 18th, 2023 Company Industry JurisdictionThis ESCROW AGREEMENT (this “Agreement”) made as of [●], 2023, by and among ZyVersa Therapeutics, Inc. (the “Issuer”), whose address and other information appears on the Information Sheet (as defined herein) attached to this Agreement, and Continental Stock Transfer & Trust Company, 1 State Street, 30th Floor, New York, NY 10004 (the “Escrow Agent”).